SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Meihua International Medical Technologies Co., (MHUAF) — Feb 24, 2026

Meihua International Medical Technologies Co., Ltd.
Date: Feb. 24, 2026 · CIK: 0001835615 · Accession: 0001213900-26-019927

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-293682

Date
February 24, 2026
Author
/s/ Leyi Lee
Form
CORRESP
Company
Meihua International Medical Technologies Co., Ltd.

Letter

Meihua International Medical Technologies Co., Ltd.

88 Tongda Road, Touqiao Town, Guangling District

Yangzhou, China, 225000

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C., 20549

Attention: Nicholas O'Leary

February 24, 2026

Re: Meihua International Medical Technologies Co., Ltd.

Registration Statement on Form F-3 (File No. 333-293682)

Filed on February 24, 2026

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Meihua International Medical Technologies Co., Ltd. hereby requests acceleration of effectiveness of the above referenced Registration Statement, so that it will become effective at 5:00 p.m., Eastern Time, on February 25, 2026, or as soon as thereafter practicable.

Very truly yours,
/s/ Leyi Lee

Show Raw Text
CORRESP
 1
 filename1.htm

 Meihua International Medical Technologies Co.,
Ltd.

 88 Tongda Road, Touqiao Town, Guangling District

 Yangzhou, China, 225000

 Via EDGAR

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, NE

 Washington, D.C., 20549

 Attention:
 Nicholas O'Leary

 February 24, 2026

 Re:
 Meihua International Medical Technologies Co., Ltd.

 Registration Statement on Form F-3 (File No. 333-293682)

 Filed on February 24, 2026

 Ladies and Gentlemen:

 Pursuant to Rule 461 under the Securities Act
of 1933, as amended, Meihua International Medical Technologies Co., Ltd. hereby requests acceleration of effectiveness of the above referenced
Registration Statement, so that it will become effective at 5:00 p.m., Eastern Time, on February 25, 2026, or as soon as thereafter practicable.

 Very truly yours,

 /s/ Leyi Lee

 Name:
 Leyi Lee

 Title:
 Chief Executive Officer

 cc:
 Joan Wu, Esq.

 Hunter Taubman Fischer & Li LLC